Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.
Qian M, Zhang H, Kham SK, Liu S, Jiang C, Zhao X, Lu Y, Goodings C, Lin TN, Zhang R, Moriyama T, Yin Z, Li Z, Quah TC, Ariffin H, Tan AM, Shen S, Bhojwani D, Hu S, Chen S, Zheng H, Pui CH, Yeoh AE, Yang JJ.
Genome Res
27 :
2017
185-195
83
Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia.
Ngoc PCT, Tan SH, Tan TK, Chan MM, Li Z, Yeoh AEJ, Tenen DG, Sanda T.
Leukemia
32 :
2018
2138-2151
33
Mutational and transcriptomic profiling of acute leukemia of ambiguous lineage reveals obscure but clinically important lineage bias.
Lao ZT, Ding LW, An O, Hattori N, Sun QY, Tan KT, Mayakonda A, Chuan WG, Madan V, Lin DC, Yang H, Koeffler HP.
Haematologica
104 :
2019
e200-e203
8
The Identification and Interpretation of cis-Regulatory Noncoding Mutations in Cancer.
Patel MB, Wang J.
High Throughput
8 :
2018
E1
4
RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia.
Koschut D, Ray D, Li Z, Giarin E, Groet J, Alić I, Kham SK, Chng WJ, Ariffin H, Weinstock DM, Yeoh AE, Basso G, Nižetić D.
Oncogene
40 :
2021
746-762
8
Short H2A histone variants are expressed in cancer.
Chew GL, Bleakley M, Bradley RK, Malik HS, Henikoff S, Molaro A, Sarthy J.
Nat Commun
12 :
2021
490
30
Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia.
Li Z, Lee SHR, Chin WHN, Lu Y, Jiang N, Lim EH, Coustan-Smith E, Chiew KH, Oh BLZ, Koh GS, Chen Z, Kham SKY, Quah TC, Lin HP, Tan AM, Ariffin H, Yang JJ, Yeoh AE.
Blood Adv
5 :
2021
5226-5238
27
Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia.
Zhao X, Wang P, Diedrich JD, Smart B, Reyes N, Yoshimura S, Zhang J, Yang W, Barnett K, Xu B, Li Z, Huang X, Yu J, Crews K, Yeoh AEJ, Konopleva M, Wei CL, Pui CH, Savic D, Yang JJ.
Nat Commun
13 :
2022
5401
8
USP1 promotes the aerobic glycolysis and progression of T-cell acute lymphoblastic leukemia via PLK1/LDHA axis.
Liu S, Xiang Y, Wang B, Gao C, Chen Z, Xie S, Wu J, Liu Y, Zhao X, Yang C, Yue Z, Wang L, Wen X, Zhang R, Zhang F, Xu H, Zhai X, Zheng H, Zhang H, Qian M.
Blood Adv
7 :
2023
3099-3112
8
TALLSorts: a T-cell acute lymphoblastic leukemia subtype classifier using RNA-seq expression data.
Gu A, Schmidt B, Lonsdale A, Jalaldeen R, Kosasih HJ, Brown LM, Sadras T, Ekert PG, Oshlack A.
Blood Adv
7 :
2023
7402-7406
2
DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers.
Pineda JMB, Bradley RK.
Elife
12 :
2024
RP89017
4
Molecular and pharmacological heterogeneity of ETV6::RUNX1 acute lymphoblastic leukemia.
Li Z, Zhao H, Yang W, Maillard M, Yoshimura S, Hsiao YC, Huang X, Gocho Y, Rowland L, Brown A, Choi L, Crews KR, Mullighan CG, Brady SW, Cheng C, Chang TC, Wu G, Loh ML, Yeoh AEJ, Antillon-Klussmann F, Jeha S, Inaba H, Yu J, Pui CH, Karol SE, Evans WE, Yang JJ.
Nat Commun
16 :
2025
1153
1
